Trial Profile
Retrospective Multi-centre Data Collection on UK Use of Aqueous Zanamivir
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Aug 2023
Price :
$35
*
At a glance
- Drugs Zanamivir (Primary) ; Zanamivir (Primary)
- Indications Influenza A virus H1N1 subtype
- Focus Adverse reactions; Therapeutic Use
- 01 Oct 2014 Status changed from recruiting to completed as reported by United Kingdom Clinical Research Network record.
- 08 Mar 2014 Planned End Date changed from 31 Oct 2013 to 30 Apr 2014 as reported by United Kingdom Clinical Research Network record.
- 08 Mar 2014 Status changed from active, no longer recruiting to recruiting as reported by United Kingdom Clinical Research Network record.